Thr277

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr277 - KIFC1 (mouse)

Site Information
VVCLRQKtEAQVTLL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 599813100

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Relevant cell line - cell type - tissue:	BaF3 ('B lymphocyte, precursor') [JAK3 (human), transfection] ( 1 )

References
1	Degryse S, et al. (2017) Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia. Leukemia 32 28852199 Curated Info

PhosphoSitePlus^® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more